Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
Quick Stats
Jun 15, 202650.1
AI Score
HOLD0.33
Volume Ratio
Aug 05, 2026
Next Earnings
12
+ve Days (30d)
18
-ve Days (30d)
MCRB Stock Summary
Last updated
MCRB is currently trading at $5.76, positioned below its 200-day moving average of $13.28, suggesting bearish momentum. The stock has a 52-week range of $5.63 to $29.98.
Technical Analysis: The 50-day moving average stands at $7.7, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads , suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is , which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates MCRB at 50.1/100 with a HOLD recommendation.
MCRB Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
MCRB Price vs Max Options Open Interest
MCRB Max Change In Options Open Interest
MCRB Options - Sort by Max open Interest (near term)
15th June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MCRB Daily Out of Money Options - Sort by Max open Interest (near term)
15th June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MCRB Daily In the Money Options - Sort by Max open Interest (near term)
15th June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MCRB Most Active Options by Volume(near term)
15th June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Seres Therapeutics, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
MCRB Moving Averages Analysis
MCRB (Seres Therapeutics, Inc.) Simple Moving Averages
Moving Averages are last updated Jun 15, 2026
| Days | MA |
|---|---|
| 10 | 6.49 |
| 20 | 7.06 |
| 30 | 7.3 |
| 50 | 7.7 |
| 100 | 9.15 |
| 200 | 13.28 |
MCRB Fundamental Analysis
| P/E (Forward) | 10.2564 |
| P/E (Trailing) | -- |
| Market Cap ($) | 61.8 million |
| Earnings/Share ($) | -5.2 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -9.19 |
| EPS Estimate Next Year ($) | -10.28 |
| WallStreet Target Price ($) | 22 |
| Most Recent Quarter |
News: Investors in $MCRB are eagerly awaiting news of a potential offer for the company. Speculation and excitement are building as discussions about a possible deal continue. Some are questioning the legitimacy of the offer and the actions of the company's leadership.
Updated 2025-09-08 04:00:02